Corrigendum to “Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer” [Eur J Cancer 40 (18) (2004) 2717–2725] (S0959804904006719) (10.1016/j.ejca.2004.08.008));Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer

European Journal of Cancer

Volumn 40, Issue 18, 2004, Pages 2717-2725

  Martin, Tracey A ^a   Watkins, Gareth ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; MUPP 1; PCR; Prognosis; Tight junction; ZO 1; ZO 2; ZO 3

Indexed keywords

PDZ PROTEIN; PROTEIN; PROTEIN MUPP 1; PROTEIN ZO 2; PROTEIN ZO 3; PROTEIN ZO1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TIGHT JUNCTION; WESTERN BLOTTING;

EID: 9644272527     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2017.11.001     Document Type: Erratum

References (29)

1. S. Tsukita, and M. Furuse Occludin and claudins in tight-junction strands: leading or supporting players Trend Cell Biol 9 7 1999 268 273
2. W.G. Jiang, T.A. Martin, K. Matsumoto, T. Nakamura, and R.E. Mansel Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells J Cell Physiol 181 2 1999 319 329
3. V. Wong, and B.M. Gumbiner A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier J Cell Biol 136 2 1997 399 409
4. F. Hollande, E.M. Blanc, J.P. Bali, R.H. Whitehead, A. Pelegrin, and G.S. Baldwin HGF regulates tight junctions in new nontumorigenic gastric epithelial cell line Am J Physiol Gastrointest Liver Physiol 280 5 2001 G910 G921
5. Y. Tanaka, K. Irie, T. Hirota, T. Sakisaka, H. Nakanishi, and Y. Takai Ectodomain shedding of nectin-1alpha by SF/HGF and TPA in MDCK cells Biochem Biophys Res Commun 299 3 2002 472 478
6. T.A. Martin, R.E. Mansel, and W.G. Jiang Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells J Cell Physiol 192 3 2002 268 275
7. A. Chlenski, K.V. Ketels, M.S. Tsao, M.S. Talamonti, M.R. Anderson, and R. Oyasu Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma Int J Cancer 82 1 1999 137 144
8. T.A. Martin, R.E. Mansel, and W.G. Jiang HGF disrupts tight junction function of human breast cancer cells which can be reversed by NK4, the HGF-antagonist Breast Res Treat 76 Suppl. 2002 572
9. J. Ren, J. Hamada, N. Takeichi, S. Fujikawa, and H. Kobayashi Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma Cancer Res 50 2 1990 358 362
10. H. Satoh, Y. Zhong, H. Isomura, M. Saitoh, K. Enomoto, and N. Sawada Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells Exp Cell Res 222 2 1996 269 274
11. H. Tobioka, N. Sawada, Y. Zhong, and M. Mori Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration Br J Cancer 74 3 1996 439 445
12. T. Hoevel, R. Macek, O. Mundigl, K. Swisshelm, and M. Kubbies Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells J Cell Physiol 191 1 2002 60 68
13. K.B. Hoover, S.Y. Liao, and P.J. Bryant Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity Am J Pathol 153 6 1998 1767 1773
14. S.L. Kominsky, P. Argani, D. Korz, E. Evron, V. Raman, and E. Garrett Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast Oncogene 22 13 2003 2021 2033
15. W.G. Jiang, G. Watkins, J. Lane, A. Douglas-Jones, G.H. Cunnick, and M. Mokbel Prognostic value of Rho family and rho-GDIs in breast cancer Clin Cancer Res 9 17 2003 6432 6440
16. W.G. Jiang, A. Douglas-Jones, and R.E. Mansel Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer Int J Cancer 106 2003 752 757
17. W.G. Jiang, S. Hiscox, M.B. Hallett, D.F. Horrobin, R.E. Mansel, and M.C.A. Puntis Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid Cancer Res 55 1995 5043 5048
18. T.A. Martin, R.E. Mansel, and W.G. Jiang HGF/SF modulation of the expression of VE-cadherin in human vascular endothelial cells Clin Cancer Res 7 2001 734 737
19. M. Furuse, K. Fujita, T. Hiiragi, K. Fujimoto, and S. Tsukita Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin J Cell Biol 141 7 1998 1539 1550
20. M. Itoh, K. Morita, and S. Tsukita Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin J Biol Chem 274 9 1999 5981 5986
21. E.S. Wittchen, J. Haskins, and B.R. Stevenson Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3 J Biol Chem 274 49 1999 35179 35185
22. Y. Hamazaki, M. Itoh, H. Sasaki, M. Furuse, and S. Tsukita Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule J Biol Chem 277 1 2002 455 461
23. C.L. Sommers, S.W. Byers, E.W. Thompson, J.A. Torri, and E.P. Gelmann Differentiation state and invasiveness of human breast cancer cell lines Breast Cancer Res Treat 31 2-3 1994 325 335
24. J. Bell, S. Walsh, A. Nusrat, and C. Cohen Zonula occludens-1 and Her-2/neu expression in invasive breast carcinoma Appl Immunohistochem Mol Morphol 11 2 2003 125 129
25. T.N. Meyer, C. Schwesinger, and B.M. Denker Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha (12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells J Biol Chem 277 28 2002 24855 24858
26. A. Avila-Flores, E. Rendon-Huerta, J. Moreno, S. Islas, A. Betanzos, and M. Robles-Flores Tight-junction protein zonula occludens 2 is a target of phosphorylation by protein kinase C Biochem J 360 Pt 2 2001 295 304
27. A. Chlenski, K.V. Ketels, G.I. Korovaitseva, M.S. Talamonti, R. Oyasu, and D.G. Scarpelli Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues Biochim Biophys Acta 1493 3 2000 319 324
28. B.A. Glaunsinger, R.S. Weiss, S.S. Lee, and R. Javier Link of the unique oncogenic properties of adenovirus type9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2 EMBO J 20 20 2001 5578 5586
29. N. Utoguchi, H. Mizuguchi, K. Saeki, K. Ikeda, Y. Tsutsumi, and S. Nakagawa Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer Cancer Lett 89 1 1995 7 14